| P2093 | author name string | Taylor CG | |
| | Tallman DL | |
| P2860 | cites work | Positional cloning of the mouse obese gene and its human homologue | Q22251285 |
| | Role of melanocortinergic neurons in feeding and the agouti obesity syndrome | Q28300979 |
| | Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus | Q29616284 |
| | Serum immunoreactive-leptin concentrations in normal-weight and obese humans | Q29617230 |
| | Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects | Q29617231 |
| | Identification and expression cloning of a leptin receptor, OB-R | Q29620255 |
| | Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain | Q33904901 |
| | The Significance of Basal Insulin Levels in the Evaluation of the Insulin Response to Glucose in Diabetic and Nondiabetic Subjects* | Q34087250 |
| | Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells | Q34130674 |
| | Transient increase in obese gene expression after food intake or insulin administration | Q34296141 |
| | Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro | Q34377910 |
| | Abnormal splicing of the leptin receptor in diabetic mice | Q34379335 |
| | Insulin and cortisol promote leptin production in cultured human fat cells | Q34399350 |
| | Dexamethasone stimulates leptin release from human adipocytes: unexpected inhibition by insulin | Q34424728 |
| | Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. | Q34464843 |
| | Zinc and insulin sensitivity | Q35318700 |
| | Obesity and hyperleptinemia in metallothionein (-I and -II) null mice | Q35679481 |
| | Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters | Q37354703 |
| | Diet-induced obese mice develop peripheral, but not central, resistance to leptin | Q37362925 |
| | Cyclic feeding behaviour and changes in hypothalamic galanin and neuropeptide Y gene expression induced by zinc deficiency in the rat. | Q48811637 |
| | Zinc and copper in the serum of diabetic patients | Q50118026 |
| | Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms. | Q50937147 |
| | Relationships between plasma leptin and insulin concentrations, but not insulin resistance, in non-insulin-dependent (type 2) diabetes mellitus. | Q50953327 |
| | Carbohydrate intake and short-term regulation of leptin in humans. | Q50965084 |
| | Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. | Q50974022 |
| | Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice. | Q51570945 |
| | Increased plasma leptin levels are associated with fat accumulation in Japanese Americans. | Q51571088 |
| | Effects of bovine prostate powder on zinc, glucose, and insulin metabolism in old patients with non-insulin-dependent diabetes mellitus. | Q51572045 |
| | Effect of reduced dietary zinc intake on carbohydrate and Zn metabolism in the genetically diabetic mouse (C57BL/KsJ db+/db+). | Q51623982 |
| | Hyperinsulinemia increases the amount of GLUT4 mRNA in white adipose tissue and decreases that of muscles: a clue for increased fat depot and insulin resistance. | Q54310491 |
| | Zinc supplementation attenuates insulin secretory activity in pancreatic islets of the ob/ob mouse. | Q54455661 |
| | Hyperzincuria in insulin treated diabetes mellitus—its relation to glucose homeostasis and insulin administration | Q58170028 |
| | Brain neuropeptide Y: an integrator of endocrine, metabolic and behavioral processes | Q37546633 |
| | Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior | Q37690998 |
| | Zinc and insulin metabolism | Q38165789 |
| | Insulin and insulin-like growth factors in the CNS. | Q38198235 |
| | Acute cold-induced suppression of ob (obese) gene expression in white adipose tissue of mice: mediation by the sympathetic system | Q38289994 |
| | The role of neuropeptide Y in the antiobesity action of the obese gene product | Q38290434 |
| | Effects of fasting and refeeding on ob gene expression in white adipose tissue of lean and obese (ob/ob) mice | Q38293354 |
| | Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake | Q38293519 |
| | Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. | Q38319827 |
| | Zinc may regulate serum leptin concentrations in humans | Q38336610 |
| | Human plasma leptin in obese subjects and diabetics | Q38339975 |
| | Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly | Q38344746 |
| | Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome | Q38346487 |
| | Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance | Q38347472 |
| | Upregulation of leptin receptor mRNA expression in obese mouse brain. | Q38347882 |
| | Regulation of leptin receptor and NPY gene expression in hypothalamus of leptin-treated obese (ob/ob) and cold-exposed lean mice | Q38348592 |
| | Relatively low plasma leptin concentrations precede weight gain in Pima Indians | Q38348967 |
| | Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion | Q38349047 |
| | Leptin enters the brain by a saturable system independent of insulin | Q38363314 |
| | Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons | Q39695680 |
| | Neuropeptide Y, the hypothalamus, and diabetes: insights into the central control of metabolism | Q40370327 |
| | Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. | Q40452210 |
| | Endocrine abnormalities of obesity | Q40482786 |
| | Pathogenesis of non-insulin-dependent diabetes mellitus | Q40619457 |
| | Leptin stimulates glucose transport and glycogen synthesis in C2C12 myotubes: evidence for a P13-kinase mediated effect | Q41113283 |
| | Copper, Zinc, Manganese, and Magnesium Status and Complications of Diabetes Mellitus | Q41138235 |
| | Adipogenesis and obesity: rounding out the big picture | Q41193513 |
| | Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation | Q41235246 |
| | Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. | Q41275648 |
| | Evidence for a central mechanism of obesity in the Zucker rat: role of neuropeptide Y and leptin | Q41398410 |
| | Insulin resistance is central to the burden of diabetes | Q41530559 |
| | Insulin resistance is not central to the burden of diabetes | Q41530566 |
| | Regional adipocity in man. | Q41671433 |
| | Insulin stimulates both leptin secretion and production by rat white adipose tissue | Q42445145 |
| | Metabolic consequences of hyperinsulinaemia imposed on normal rats on glucose handling by white adipose tissue, muscles and liver | Q42793877 |
| | Effects of diabetes type and treatment on zinc status in diabetes mellitus | Q44579097 |
| | Insulinlike Effects of Zinc Ion in Vitro and in Vivo: Preferential Effects on Desensitized Adipocytes and Induction of Normoglycemia in Streptozocin-Induced Rats | Q45847695 |
| | Plasma leptin concentrations do not appear to decrease insulin-mediated glucose disposal or glucose-stimulated insulin secretion in women with normal glucose tolerance | Q46154346 |
| | Physiological insulinemia acutely modulates plasma leptin | Q46535852 |
| | The alphabet of weight control | Q47315738 |
| | Cloning of rat obese cDNA and its expression in obese rats | Q48074356 |
| | Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: lack of effect in other rat brain regions | Q48170490 |
| | Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. | Q48221397 |
| | Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system--II. Immunohistochemical analysis | Q48324021 |
| | Neuropeptide Y: direct and indirect action on insulin secretion in the rat. | Q48440247 |
| | Food deprivation and hypothalamic neuropeptide gene expression: effects of strain background and the diabetes mutation | Q48639843 |
| | Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. | Q48794682 |
| P433 | issue | 12 | |
| P304 | page(s) | 919-933 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Canadian Journal of Physiology and Pharmacology | Q5030248 |
| P1476 | title | Potential interactions of zinc in the neuroendocrine-endocrine disturbances of diabetes mellitus type 2. | |
| P478 | volume | 77 | |